A liver tolerates a portal antigen by generating CD11c+ cells, which select Fas ligand+ Th2 cells via apoptosis

Hepatology

Volumn 38, Issue 2, 2003, Pages 403-412

  Watanabe, Tomohiro ^a   Katsukura, Hiroaki ^a   Shirai, Yasuhiko ^a   Yamori, Masashi ^a   Nishi, Toshiki ^a   Chiba, Tsutomu ^a   Kita, Toru ^a   Wakatsuki, Yoshio ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; FLUORESCEIN ISOTHIOCYANATE; GLYCOPROTEIN P 15095; INTERLEUKIN 12; INTERLEUKIN 18; OVALBUMIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; LIVER HILUS; LIVER PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE SUBPOPULATION; TH2 CELL;

EID: 0042766875     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50343     Document Type: Article

References (30)

1. Thomson AW, Lu L. Are dendritic cells the key to liver transplant tolerance? Immunol Today 1999;20:27-32.
2. Thomson AW, Drakes ML, Zahorchak AF, O'Connell PJ, Steptoe RJ, Qian S, Lu L. Hepatic dendritic cells: immunobiology and role in liver transplantation. J Leukoc Biol 1999;66:322-330.
3. Nakano Y, Monden M, Valdivia LA, Gotoh M, Tono T, Mori T. Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats. Surgery 1992;111:668-676.
4. Morita H, Sugiura K, Inaba M, Jin T, Ishikawa J, Lian Z, Adachi Y, et al. A strategy for organ allografts without using immunosuppressants or irradiation. Proc Natl Acad Sci U S A 1998;95:6947-6952.
5. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-238.
6. Crispe IN, Dao T, Klugewitz K, Mehal WZ, Metz DP. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 2000;174:47-62.
7. Callery MP, Kamei T, Flye MW. The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding. J Surg Res 1989;46:391-394.
8. Watanabe T, Yoshida M, Shirai Y, Yamori M, Yagita H, Itoh T, Chiba T, et al. Administration of an antigen at a high dose generates regulatory CD4(+) T cells expressing CD95 ligand and secreting IL-4 in the liver. J Immunol 2002;168:2188-2199.
9. Brocker T, Riedinger M, Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 1997;185:541-550.
10. Khanna A, Morelli AE, Zhong C, Takayama T, Lu L, Thomson AW. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo. J Immunol 2000;164:1346-1354.
11. Knolle PA, Schmitt E, Jin S, Germann T, Duchmann R, Hegenbarth S, Gerken G, et al. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology 1999;116:1428-1440.
12. Murphy KM, Heimberger AB, Loh DY. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocyres in vivo. Science 1990;250:1720-1723.
13. Iwasaki A, Kelsall BL. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells. J Immunol 2001;166:4884-4890.
14. Kruisbeek AM. Preparation of cell suspensions from spleen, thymus, and lymph node. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, and Strober W, eds. Current Protocols in Immunology. New York: John Swiley & Sons, 1993:3.1.3.
15. Cycke N. Isolation of PP lymphocytes. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, and W. Strober, eds. Current Protocols in Immunology. New York: John Swiley & Sons, 1996:3.19.5.
16. Yoneyama H, Matsuno K, Zhang Y, Murai M, Itakura M, Ishikawa S, Hasegawa G, et al. Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. J Exp Med 2001;193:35-49.
17. Kayagaki N, Yamaguchi N, Nagao F, Matsuo S, Maeda H, Okumura K, Yagita H. Polymorphism of murine Fas ligand that affects the biological activity. Proc Natl Acad Sci U S A 1997;94:3914-3919.
18. Kearney ER, Pape KA, Loh DY, Jenkins MK. Visualization of peptide-specific cell immunity and peripheral tolerance induction in vivo. Immunity 1994;1:327-339.
19. Gillis S, Ferm MM, Ou W, Smith KA. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 1978;120:2027-2032.
20. Hu-Li J, Ohara J, Watson C, Tsang W, Paul WE. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J Immunol 1989;142:800-807.
21. Usui T, Wakatsuki Y, Matsunaga Y, Kaneko S, Koseki H, Kita T. Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype. J Immunol 1997;158:3197-3204.
22. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995;378:88-91.
23. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synegism with 1L-18 for IFN-gamma production. J Immunol 1998;161:3400-3407.
24. Yoshimoto T, Mizutani H, Tsutsui H, Noben-Trauth N, Yamanaka K, Tanaka M, Izumi S, et al. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol 2000;1:132-137.
25. Hoshino T, Kawase Y, Okamoto M, Yokota K, Yoshino K, Yamamura K, Miyazaki J, et al. Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function. J Immunol 2001;166:7014-7018.
26. Palmer EM, Farrokh-Siar L, Maguire van Seventer J, van Seventer GA. IL-12 decreases activation-induced cell death in human naive Th cells costimulated by intercellular adhesion molecule-1. I. IL-12 alters caspase processing and inhibits enzyme function. J Immunol 2001;167:749-758.
27. Hashimoto W, Osaki T, Okamura H, Robbins PD, Kurimoto M, Nagata S, Lotze MT, et al. Differential antitumor effects of administration of recombinant 1L-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. J Immunol 1999;163:583-589.
28. Varadhachary AS, Perdow SN, Hu C, Ramanarayanan M, Salgame P. Differential ability of T cell subsets to undergo activation-induced cell death. Proc Natl Acad Sci U S A 1997;94:5778-5783.
29. Zhang X, Brunner T, Carter L, Dutton RW, Rogers P, Bradley L, Sato T, et al. Unequal death in T helper cell (Th) 1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 1997;185:1837-1849.
30. Maldonado-Lopez R, De Smedt T, Michel P, Godfroid J, Pajak B, Heirman C, Thielemans K, et al. CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 1999;189:587-592.